Search Results 431-440 of 1057 for 씨밀레토토

1. Demyelinating Disease Clinical Trials

   The purpose of this study is to develop quantitative approaches of analyzing multimodal MRI acquisitions with the goal to improve cortical lesion detection in ...

2. Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. - Mayo Clinic

   About this study. Non-treatment extension to study A3051123, aimed at collecting data on cardiovascular safety for all participants in the A3051123 trial ...

3. Biostatistics and Bioinformatics Core - Mayo Clinic Research

   The Biostatistics and Bioinformatics Core provides statistical, bioinformatics, computational biology collaboration and data management for the ...

4. Bradley F. Boeve, M.D. - Mayo Clinic Faculty Profiles

   Boeve, M.D., include normal aging, neurodegenerative disorders that cause cognitive impairment or dementia, neurogenetics, prion disorders, and neurological ...

5. A Study to Detect Cancers Through Elective Plasma-based CancerSEEK Testing - Mayo Clinic

   The primary objective of this study is to obtain clinically characterized, whole blood specimens from cancer and healthy subjects to develop and refine assays ...

6. Clinical trials - Oncology (Medical)

   Rochester, Minn. The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and ...

7. A Study to Evaluate Intra-arterial Delivery of Mesenchymal Stem Cells for Luminal Ulcerative Colitis - Mayo Clinic

   About this study. Ulcerative Colitis (UC) is a chronic inflammatory disease affecting the mucosal lining of the colon and rectum and the incidence is ...

8. A study assessing esophageal function and remodeling with dupilumab compared with placebo for 24 weeks followed by 104 weeks open-label in adult participants with EoE - Mayo Clinic

   The purpose of this study is to assess the effect of dupilumab compared to placebo on esophageal distensibility at Week 24. Participation eligibility.

9. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

   All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

10. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

    About this study. The purpose of this study is to estimate the rate of sustained MRD negativity (MRD negative status at any point, with a repeated MRD ...